France's health authorities have decided that a higher risk of blood clots, strokes and thrombosis in the latest versions of birth control pills pose an unacceptable danger to women's health. As a result, the government has changed its prescription guidelines for oral contraceptives. The decision could affect 2.5 million women in France and many more overseas, should other countries follow suit.
AFP (Oct. 18, 2013) Marion Larat is the first woman in France to take the German pharmaceutical company Bayer to court over newer-generation birth control pills that caused her to have a stroke and left her severely ... watch video
AFP (Apr. 8, 2013) South Africa's health minister launches a new single dose anti-AIDS drug, which reduces the need for HIV positive patients to take multiple pills each day. The country has the largest HIV positive ... watch video
AP (Mar. 25, 2014) The Supreme Court seemed divided Tuesday over whether employers' religious beliefs can free them from a part of the new health care law that requires that they provide coverage of birth control for ... watch video
May 25, 2015 Certain special fats found in blood are essential for human brain growth and function, new research suggests. New published studies show that mutations in the protein Mfsd2a ... read more
May 25, 2015 Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving ... read more
Aug. 1, 2014 Women who recently used birth control pills containing high-dose estrogen and a few other formulations had an increased risk for breast cancer, whereas women using some other formulations did not, ... read more
Apr. 18, 2011 Drospirenone, the top-selling oral contraceptive marketed as Yaz or Yasmin in the US and Canada, doesn't carry any more risk of gall bladder disease than the older generation of birth control ... read more